Noile-Immune Biotech Inc. researches and develops CAR-T cells for cancer immunotherapies. The company was incorporated in 2015 and is headquartered in Minato, Japan.
Stock data | 2024 | Change |
---|---|---|
Price | $1.29 | N/A |
Market Cap | $55.82M | N/A |
Shares Outstanding | 43.28M | N/A |
Employees | 0 | N/A |